![Hui Gu Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hui Gu Chen
Direktor/Vorstandsmitglied bei Hainan Zhonghe Pharmaceutical Co., Ltd.
Aktive Positionen von Hui Gu Chen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hainan Zhonghe Pharmaceutical Co., Ltd.
![]() Hainan Zhonghe Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hainan Zhonghe Pharmaceutical Co., Ltd. principally engages in the research, development, and manufacturing of peptide drugs. Its products include thymopen, tinthymalfasin, somatostatin, desmopressindesm, opressinoctreotide, atosiban, and entecavir. The company was founded in April 17, 1995 and is headquartered in Haikou, China. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Hui Gu Chen
Statistik
International
China | 2 |
Operativ
Director/Board Member | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Hainan Zhonghe Pharmaceutical Co., Ltd.
![]() Hainan Zhonghe Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hainan Zhonghe Pharmaceutical Co., Ltd. principally engages in the research, development, and manufacturing of peptide drugs. Its products include thymopen, tinthymalfasin, somatostatin, desmopressindesm, opressinoctreotide, atosiban, and entecavir. The company was founded in April 17, 1995 and is headquartered in Haikou, China. | Health Technology |
- Börse
- Insiders
- Hui Gu Chen
- Erfahrung